Found: 14
Select item for more details and to access through your institution.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 781, doi. 10.1111/bjh.19058
- By:
- Publication type:
- Article
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 136, doi. 10.1111/bjh.17807
- By:
- Publication type:
- Article
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 779, doi. 10.1111/bjh.17447
- By:
- Publication type:
- Article
Risk of infection in MPN patients in the era of Covid‐19: A prospective multicenter study of 257 patients from the CML‐MPN Quebec Research Group.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E200, doi. 10.1002/ajh.26159
- By:
- Publication type:
- Article
PD‐L1 expression predicts efficacy in the phase II SPiReL trial with MVP‐S, pembrolizumab, and low‐dose CPA in R/R DLBCL.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 191, doi. 10.1111/ejh.13982
- By:
- Publication type:
- Article
Featured Cover.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. i, doi. 10.1111/ejh.14043
- By:
- Publication type:
- Article
Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients.
- Published in:
- Transfusion, 2006, v. 46, n. 2, p. 174, doi. 10.1111/j.1537-2995.2006.00695.x
- By:
- Publication type:
- Article
Early events in leukemogenesis in P190Bcr-abl transgenic mice.
- Published in:
- Oncogene, 2000, v. 19, n. 38, p. 4362, doi. 10.1038/sj.onc.1203804
- By:
- Publication type:
- Article
When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E602, doi. 10.1002/ajh.24838
- By:
- Publication type:
- Article
Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CYCLOSPORIN A INDUCED REMISSION OF CD4 + T-CLL ASSOCIATED WITH EOSINOPHILIA AND FASCIITIS.
- Published in:
- British Journal of Haematology, 1992, v. 80, n. 2, p. 252, doi. 10.1111/j.1365-2141.1992.tb08909.x
- By:
- Publication type:
- Article